Atropine eye drops to control myopia progression

15 August 2019
Volume 20, Issue 3

This paper critically reviews scientific studies investigating the efficacy of atropine at regressing myopia progression in children.

How effective are atropine eye drops at reducing myopia progression in children? provides a critical appraisal of the literature with regard to clinical use of atropine for myopia control. Low-dose atropine is an effective pharmacological myopia control strategy. Although not yet available commercially in the UK, clinical trials are ongoing at present and the drug could be adopted in the near future for myopia control.

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

With half the world's population estimated to be myopic by 2050, Olivier Denève, our Head of Policy and Public Affairs, asks how we can explain the risks and benefits to patients.

Heart attacks transiently increase in number when the clocks go forward. Diabetic retinopathy and glaucoma can interfere with the body’s sleep-wake cycles. Becky McCall examines the relationship between the eye and sleep.

Here we summarise three research papers from a recent issue of Optometry in Practice.